Cultivation License – MJ Shareholders https://mjshareholders.com The Ultimate Marijuana Business Directory Tue, 09 Aug 2022 16:39:05 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.5 Village Farms Announces Leli Holland’s Receipt of Final Cultivation License and Majority Ownership of 85% of Leli Holland https://mjshareholders.com/village-farms-announces-leli-hollands-receipt-of-final-cultivation-license-and-majority-ownership-of-85-of-leli-holland/ Tue, 09 Aug 2022 16:39:05 +0000 https://www.cannabisfn.com/?p=2958221

Ryan Allway

August 9th, 2022

News, Top News


 Village Farms Will Contribute to Reshaping the Future of Recreational Cannabis in the Netherlandsthe First Major European Country to Permit Large Scale Cultivation and Distribution of Recreational Cannabis 

VANCOUVER, BCAug. 9, 2022 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced Leli Holland B.V. (“Leli Holland”) has been granted the tenth and final license to cultivate cannabis legally in the Netherlands (the “License”) under the Dutch Closed Supply Chain Experiment program (the “Dutch Program”), which is expected to be commence operating next year. Subsequently, Village Farms completed acquisition of 85% of privately held Leli Holland under its previously announced purchase option agreement, enabling Village Farms to directly participate as a Netherlands-based cultivator and distributor of cannabis in the Dutch Program, under which the Netherlands will become the first major European country to permit large scale cultivation and distribution of recreational cannabis.

The Dutch Program is intended to evaluate determine whether and how controlled cannabis can be legally supplied to existing retailers (known as “coffee shops”) and what the effects of such would be, specifically in the context of concerns around public order and safety, public health and crime amidst the current Dutch cannabis policy, which tolerates the sale and use of cannabis for recreational purposes but prohibits production and distribution to coffee shops.

“We are so proud to come home to the Netherlands as one of just ten companies that will be licensed to cultivate recreational cannabis and distribute high quality cannabis products to coffee shops in the Netherlands,” said Michael DeGiglio, CEO Village Farms. “Village Farms has a long, rich history in the Netherlands and majority ownership of Leli will allow for direct and meaningful participation in the Dutch Program and contribute to reshaping the future of recreational cannabis in the Netherlands. Village Farms’ Vice President of European Cannabis, Orville Bovenschen, born and raised in the Netherlands, will lead our cannabis venture there, splitting his time between our head office in Orlando and the Netherlands. We look forward, to bringing our deep expertise and decades of experience in the design, construction, start up and operation of high-performance, low-cost controlled environment agriculture facilities to the Dutch cannabis industry.”

“For decades, the Netherlands has been a global pioneer in the decriminalisation of cannabis and the Dutch Program is an historic, positive step in the evolution of the country’s cannabis regulation that will make it the first major European country to permit large scale recreational cultivation. Utilizing the existing retail sales channel will benefit Dutch consumers greatly, and very much look forward to supplying these consumers with high quality, safe and tested cannabis, in the participating jurisdictions. We expect that our Dutch roots, combined with our deep Canadian experience, will contribute to a successful pilot program, and the potential of the program to be expanded nationally.”

Mr. DeGiglio added, “As cannabis sentiment shifts favorably, we are pursuing, and will continue to pursue, other European opportunities as they unfold. Our direct participation in the Dutch Program, leveraging our position as a top Canadian Licensed Producer with EU-GMP certification, strongly positions Village Farms for success in these markets as they legalize.”

About the Netherlands Dutch Closed Supply Chain Experiment

The Dutch Program is scheduled to operate for a minimum of four years with the potential for national expansion. The total supply requirement for the ten approved producers participating in the Dutch Supply Chain Experiment is specified by the Netherlands government to be approximately a minimum of 65,000 kilograms of dried flower annually. A brief description of the Dutch Program can be found at https://www.government.nl/topics/drugs/controlled-cannabis-supply-chain-experiment.

About Village Farms International, Inc.

Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods opportunities, with a strong foundation as a leading fresh produce supplier to grocery and large-format retailers throughout the US and Canada, and new high-growth opportunities in the cannabis and CBD categories in North America and selected markets internationally.

In Canada, the Company’s wholly-owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer and one of the best-selling brands.

In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD brands and e-commerce platforms in the country.  Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US high-THC cannabis market via multiple strategies, leveraging one of the largest greenhouse operations in the country (more than 5.5 million square feet in West Texas), as well as the operational and product expertise gained through Pure Sunfarms’ cannabis success in Canada.

Internationally, Village Farms is targeting selected, nascent, legal cannabis and CBD opportunities with significant medium- and long-term potential, with an initial focus on the Asia-Pacific region and the Netherlands in Europe.

Cautionary Statement Regarding Forward-Looking Information

This Press Release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is subject to the safe harbor created by those sections. This Press Release also contains “forward-looking information” within the meaning of applicable Canadian securities law. We refer to such forward-looking statements and forward-looking information collectively as “forward-looking statements”. Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans (including internationally as a result of our acquisition of Leli Holland), litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “try”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this Press Release are subject to risks that may include, but are not limited to: our limited operating history, including that of Rose LifeScience Inc. (“Rose”), Balanced Health Botanicals, LLC (“Balanced Health”), Pure Sunfarms, Inc.(“Pure Sunfarms”) and our operations of growing hemp in the United States; the legal status of Pure Sunfarms, Rose and Balanced Health cannabis business; risks relating to the integration of Balanced Health and Rose into our cannabis business; risks related to international expansion through our investment in Leli Holland; risks relating to obtaining additional financing, including our dependence upon credit facilities; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses; market position, ability to leverage current business relationships for future business involving hemp and cannabinoids, the ability of Pure Sunfarms and Rose to cultivate and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and licenses (e.g., Pure Sunfarms ability to obtain licenses for its Delta 2 greenhouse facility as well as additional licenses under the Canadian act respecting cannabis to amend to the Controlled Drugs and Substances Act, the Criminal Code and other Acts, S.C. 2018, c. 16 (Canada) for its Delta 3 greenhouse facility), and changes in our regulatory requirements; risks relating to conversion of our greenhouses to cannabis production for Pure Sunfarms; risks related to rules and regulations at the U.S. federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; the ongoing and developing COVID-19 pandemic; and tax risks.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this Press Release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this Press Release. In particular, we caution you that our forward-looking statements are subject to the ongoing and developing circumstances related to the COVID-19 pandemic, which may have a material adverse effect on our business, operations and future financial results.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this Press Release relate only to events or information as of the date on which the statements are made in this Press Release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Fiore Cannabis Provides Corporate Updates Including Developments at Apex Cannabis Facility in Las Vegas https://mjshareholders.com/fiore-cannabis-provides-corporate-updates-including-developments-at-apex-cannabis-facility-in-las-vegas/ Tue, 05 Oct 2021 15:48:33 +0000 https://www.cannabisfn.com/?p=2935431

Ryan Allway

October 5th, 2021


Cannabis company positioned to benefit from U.S. legalization efforts with its core operating markets clearly defined as Nevada and California

Kelowna, British Columbia and Las Vegas, Nevada–(Newsfile Corp. – October 5, 2021) – Fiore Cannabis (CSE: FIOR) (OTCQX: FIORF) (“Fiore” or the “Company”), a licensed multi-state cannabis cultivator, producer and retailer, today provided a number of corporate updates including developments regarding its Apex cannabis cultivation and production facility near Las Vegas, Nevada.

The Company’s partner, which has an option to purchase a cannabis cultivation licence for the Apex site from Fiore upon U.S. federal legalization, has completed construction of its modular facility and is expected to begin pouring the pad onsite in the coming month. Allied Corp. (OTCQB: ALID) (“Allied”) has the option to buy the licence from Fiore for US$1.5 million as per an agreement signed on March 31, 2021. Fiore will be managing the selection of cannabis strains as well as the new operation once it commences business, which is expected during the fourth quarter of 2021.

Fiore intends to use funds generated from the licence sale to advance additional expansion activity at the seven-acre Apex site that can enhance cultivation capacity for Fiore and ultimately deliver additional cannabis products into the growing and high-margin Nevada market. The Company has developed strong relationships with the Nevada retail market for distribution purposes as Fiore’s award-winning, high-THC organic cannabis products are highly sought after.

“Fiore’s Apex Facility in Las Vegas is our company’s crown jewel,” said Erik Anderson, President and CEO of Fiore Cannabis. “In Nevada, we serve a growing high-demand market with a major tourist destination. This is why we applaud the U.S. government’s ongoing push towards legalizing cannabis on a federal basis and the benefits that could bring to cannabis markets across the country.”

An additional development at the Apex Facility includes the successful relaunch of Fiore’s Diamante extraction lab operation. The Company added the processing of crude cannabis extracts into a number of concentrate-based products marketed under the Diamante Labs brand name. Extraction operations are forecasted to begin generating meaningful product sales for Fiore in the third quarter of 2021 with key dispensaries lined up to retail the products in the Las Vegas market. Diamante’s products, including Live Resin Vape Pens, Diamonds, Live Resin and Sugar Waxes, are targeted at discerning cannabis connoisseurs and are already drawing interest in the Las Vegas market.

Anderson noted, “We have put a major focus on our U.S. operations and specifically the Nevada market due to the robust nature of the market and the ongoing growth in demand for premium quality cannabis products. Our Apex facility has received industry recognition as well as awards for its specific genetics, strains and growing properties. Producing top-quality products is our sweet spot at Fiore so we are certainly located in a desirable market with Las Vegas as a base and see additional opportunities to expand our Company’s footprint in the state.”

Fiore will be providing tours of the enhanced Apex Facility and its extraction operations to strategic partners and customers during MJBizCon being held in Las Vegas from October 20 to 22, 2021.

About Fiore Cannabis

Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) is a publicly traded company that has been investing in the development of recreational and medical cannabis products since 2014. The Company has expanded its operations to include cultivation, production and retail offerings in the key North American legal jurisdictions of Nevada and California. Fiore’s portfolio of brands caters to diverse consumer and patient experiences, with brands and products that address recreational, medical, wellness as well as new consumer experience preferences. Current brands include Fiore Cannabis, Diamante Labs, Surfer and The Weekender. The Company operates retail cannabis outlets through its Green Leaf Wellness brand. For more information, please visit www.fiorecannabis.com.

For Further Information
Erik Anderson
President and CEO
1-877-438-5448 Ext. 713
[email protected]

Cannabis Industry Involvement

The Company owns marijuana licenses in Nevada and California. Marijuana is legal in each state; however, marijuana remains illegal under United States federal law and the approach to enforcement of U.S. federal law against marijuana is subject to change. Shareholders and investors need to be aware that federal enforcement actions could adversely affect their investments and that the Company’s ability to support continuing U.S.-based operations and its access private and public capital could be materially adversely affected.

Forward-Looking Information

This news release contains forward-looking statements or information that relate to our current expectations and views of future events, including in respect of the sale of the cultivation license, the entering into of definitive agreements in relation thereto, the strategic goals of the Company, the future growth and expansion plans for the Apex facility including the extraction lab’s operations, the construction of the Allied facility, the collaboration between Allied and the Company in respect of the new operations, the entering into of cost sharing and revenue sharing arrangements between the Company and Allied, the involvement of the Company in the operations of such facility, the assistance by the Company with certain aspects of marketing and product development in collaboration with Allied, the use of proceeds of the sale of the cultivation licenses, legalization of cannabis in the U.S. and the timing of such, the ratification of laws related to the banking aspects of the cannabis industry, the production and sale of extract products, and the number of retail locations likely to carry such products. Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as “anticipate”, “objective”, “may”, “will”, “might”, “should”, “could”, “can”, “intend”, “expect”, “believe”, “estimate”, “predict”, “potential”, “plan”, “is designed to”, “project”, “continue”, or similar expressions suggest future outcomes or the negative thereof or similar variations. These forward-looking statements are based on the Company’s current projections and expectations about future events and financial trends that management believes might affect its financial condition, results of operations, business strategy and financial needs, and on certain assumptions and analysis made by the Company in light of the experience and perception of historical trends, current conditions and expected future developments and other factors management believes are appropriate.

Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Such factors include, among others: the risks and uncertainties identified in the Company’s reports and filings with the applicable Canadian securities regulators, risks and uncertainties related to the entering into of definitive agreements on terms acceptable to the Company or at all, risks and uncertainties related to the successful transfer of the cultivation license, receipt of the purchase price thereof, the effects and outcomes of any collaboration between the Company and Allied, changes to the legislative regime to which the Company and Allied are subject to, the cultivation, production and sale of cannabis products in Nevada and the saleability of future harvests and the political and social climate in the U.S. in respect of cannabis legalization. Although the Company believes that any forward-looking information and statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such information and statements, there can be no assurance that any such forward-looking information and statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking information and statements. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>
Cannara’s Valleyfield Facility Receives Processing and Cultivation License https://mjshareholders.com/cannaras-valleyfield-facility-receives-processing-and-cultivation-license/ Mon, 27 Sep 2021 18:03:08 +0000 https://www.cannabisfn.com/?p=2935062

Ryan Allway

September 27th, 2021


0 000 plants to be propagated in the re-designed Valleyfield zones to replicate indoor growing conditions

MONTREALSept. 27, 2021 /CNW Telbec/ – Cannara Biotech Inc. (“Cannara” or the “Company“) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega cultivation facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it has received the license for cultivation and processing at its one million square foot cultivation and manufacturing facility in Valleyfield, Quebec (“Valleyfield Facility” or “Valleyfield“).

Cannara Biotech Inc. Logo (CNW Group/Cannara Biotech Inc.)
Cannara Biotech Inc. Logo (CNW Group/Cannara Biotech Inc.)

The majority of zones in the recently acquired greenhouse are being repurposed as an indoor facility to achieve the same growing conditions as Cannara’s Farnham Facility, home of Tribal, Orchid CBD and Nugz. In the Company’s first quarter in market, product sales surpassed $7M with supply capabilities as the limiting factor. This ready build facility will allow the company to fast-track time to market and will significantly increase product supply bolstering the company’s revenues and footprint into new markets.

Highlights:

  • The first 10,00 plants will be propagated in the first week of November 2021;
  • The fully licensed and automated Valleyfield Facility outfitted with climate control and growing systems is comprised of 24 independent growing zones. Cannara will continue to strategically activate these zones to meet the significantly growing cannabis demand in Quebec;
  • Cannara has redesigned the independent growing zones at the Valleyfield Facility to replicate indoor growing conditions including growing without utilizing the sun and to apply standard operating procedures used at its Farnham Facility to maintain consistency and quality of its product.

“By recreating an indoor environment and growing without natural sunlight, we can achieve absolute consistency and increase our production of premium-grade cannabis products in Valleyfield,” said Zohar Krivorot, President & Chief Executive Officer of Cannara Biotech Inc. “Securing the license for Valleyfield in the span of three months since acquisition is a testament of our commitment and determination to grow Cannara. We believe strongly in our model, to deliver the highest quality at some of the most affordable prices to consumers.”

About Cannara Biotech Inc.
Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. Cannara owns two mega cultivation facilities based in Quebec spanning over 1,650,000 sq. ft., providing the Company with 125,000kg of potential annualized cultivation output. Leveraging Quebec’s low electricity costs, Cannara’s facilities produce craft cultivated premium-grade cannabis products at an affordable price. For more information, please visit cannara.ca.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding “Forward-Looking” Information
This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company’s current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Cannara Biotech Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


]]>